MarketPeel
Insider Trading Intelligence
NC

Nathan Caffo

CADL
CHIEF BUSINESS OFFICER · CANDEL THERAPEUTICS, INC. · CIK 0001816992
FILING MIX · LIFETIME75%/25%
BUYS
3
SELLS
1
TOTAL VALUE
$48.0K
COMPANIES
2
ACTIVE SINCE
Jul 2020
HOLDINGS NOW
17,254
AVG SELL PX
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Nathan Caffo, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+3.97%+0.25%+3.72%+3.72%
14d1+100.00%+13.15%+1.01%+12.14%+12.14%
30d1+100.00%+9.59%+2.18%+7.41%+7.41%
60d1+100.00%+43.15%+0.77%+42.38%+42.38%
90d1+100.00%+57.53%+3.34%+54.19%+54.19%
180d1+0.00%-13.84%-0.74%-13.10%-13.10%
1y1+0.00%-57.53%-5.17%-52.36%-52.36%
2y1+0.00%-85.62%+6.89%-92.50%-92.50%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
FLOW · 3 buys / 1 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CADL
CANDEL THERAPEUTICS, INC.
PURCHASE
Chief Business Officer
6,000$8.00$48.0K6,000Jul 29, 2021Aug 2, 2021View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
Chief Business Officer
10,5290Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASE
Chief Business Officer
10,52911,254Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
22,79422,794Jul 16, 2020Jul 17, 2020View →
Other insiders · CADL
Loading peer insiders…
About this filer
CIK 0001816992
ROLE
Chief Business Officer
PRIMARY
CADL
COMPANIES
2
ACTIVE SINCE
Jul 2020
MARKETPEEL · /INSIDER/0001816992DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback